drug · antibody
siplizumab
Phase 2updated 3mo agoby ITB-Med AB🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 4Antibody drug with a maximum clinical stage of Phase 2 (across all indications), with 11 investigational indications.
targets
T-cell surface antigen CD2
all catalysts(1)
Trials studying siplizumab
- phase2A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant
- phase2Siplizumab for Sickle Cell Disease Transplant
- phase2Delayed Tolerance Through Mixed Chimerism
- phase1A Study of SIPLIZUMAB in AILD and LT Patients
- EP1Tolerance Through Mixed Chimerism (Sip-Tego)
- EP1An Open-label, Time-lagged, Dose-escalation Study to Evalaute the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that